Industrial preparation of heterocyclic modulators of lipid synthesis

By adopting hydrolysis and condensation reactions under alkaline conditions during the preparation of SGL1, combined with the use of hydrogen peroxide, the problems of by-product production and low yield are solved, and efficient and high purity preparation of SGL1 is achieved, which is suitable for industrial applications.

CN119080742APending Publication Date: 2024-12-06GANNEX PHARMA CO LTD
View PDF 0 Cites 2 Cited by

Patent Information

Application Number
CN202310658687.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-06-05
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

The prior art has problems with low by-product generation and yield when preparing SGL1 compounds, especially in the hydrolysis reaction, which is difficult to effectively control, which affects the purity and yield of the product.

Method used

The hydrolysis reaction under alkaline conditions is adopted, and an aqueous solution of hydrogen peroxide is added to the hydrolysis reaction. The hydrolysis of cyano groups is prevented by the oxidation of hydrogen peroxide, thereby inhibiting the generation of by-products; the compound SGL1-A and dimethylaminoacetaldehyde are condensated dimethyl Methanol and hydrazine acetate reacted, followed by hydrolysis and condensation reaction under alkaline conditions to gradually prepare the target compound SGL1.

Benefits of technology

It improves the yield of SGL1, reduces the generation of impurities, is suitable for industrial applications, and realizes an efficient preparation process, with a yield of more than 90%.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004268457400000011
    Figure BDA0004268457400000011
  • Figure BDA0004268457400000031
    Figure BDA0004268457400000031
  • Figure BDA0004268457400000032
    Figure BDA0004268457400000032
Patent Text Reader

Abstract

The invention discloses industrial preparation of a heterocyclic regulator for lipid synthesis, and a method for preparing a compound SGL1 comprises the following steps: carrying out hydrolysis reaction on a compound SGL1-SM1 under an alkaline condition to obtain a compound SGL1-A; the compound SGL1-A, dimethylaminoacetaldehyde dimethyl acetal and hydrazine acetate are subjected to a reaction, and a compound SGL1-B is obtained; the compound SGL1-B is subjected to a hydrolysis reaction under the alkaline condition, and a compound SGL1-C is obtained; the compound SGL1-C and a compound SGL1-SM2 are subjected to a reaction, and the compound SGL1 is obtained.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] field

[0002] The present disclosure relates generally to the field of medicinal chemistry and, more particularly, to the field of drug synthesis.

[0003] background

[0004] SGL1 compound, also known as ASC40 (codenamed TVB-2640 abroad), is a potent and safe selective oral small molecule inhibitor of fatty acid synthase. Its chemical name is 4-(1-(4-cyclobutyl-2-methyl-5-(5-methyl-4H-1,2,4-triazol-3-yl)benzoyl)piperidin-4-yl)benzonitrile. Its molecular formula is C 27 H 31 N5O2, the structural formula is as follows:

[0005]

[0006] Overview

[0007] In one aspect, the present disclosure relates to a method for preparing compound SGL1-A, comprising: subjecting compound SGL1-SM1 to a hydrolysis reaction under alkaline conditions, wherein an aqueous solution of hydrogen peroxide is added to the hydrolysis reaction.

[0008] In another aspect, the present disclosure relates to a method for preparing compound SGL1-B, comprising: reacting compound SGL1-A with dimethylaminoacetaldehyde dimethyl acetal and hydrazine acetate.

[0009] In yet another aspect, the present disclosure relates to a method for preparing compound SGL1-C, comprising: subjecting compound SGL1-B to a hydrolysis reaction under alkaline conditions.

[0010] In yet another aspect, the present disclosure relates to a method for preparing compound SGL1, comprising: reacting compound SGL1-C with compound SGL1-SM2.

[0011] On the other hand, the present disclosure relates to a method for preparing compound SGL1, which includes: the method for preparing compound SGL1-A described in the present disclosure; and / or the method for preparing compound SGL1-B described in the present disclosure; and / or the method for preparing compound SGL1-C described in the present disclosure; and / or the method for preparing compound SGL1 described in the present disclosure.

[0012] On the other hand, the present disclosure relates to a method for preparing compound SGL1, which comprises: subjecting compound SGL1-SM1 to a hydrolysis reaction under alkaline conditions to obtain compound SGL1-A; reacting compound SGL1-A with dimethylaminoacetaldehyde dimethyl acetal and hydrazine acetate to obtain compound SGL1-B; subjecting compound SGL1-B to a hydrolysis reaction under alkaline conditions to obtain compound SGL1-C; and reacting compound SGL1-C with compound SGL1-SM2 to obtain compound SGL1.

[0013] Details

[0014] In the following description, certain specific details are included to provide a comprehensive understanding of each disclosed embodiment. However, those skilled in the relevant art will recognize that the embodiments can still be implemented without using one or more of these specific details and using other methods, components, materials, etc.

[0015] Unless otherwise required in this application, throughout the specification and the appended claims, the words "including", "comprising", "containing", and "having" should be interpreted as having an open, inclusive meaning, ie, "including but not limited to".

[0016] As used in this disclosure and the appended claims, singular references without indications of quantity include plural references unless the context clearly dictates otherwise.

[0017] References throughout the specification to "one embodiment," "an embodiment," "in another embodiment," or "in certain embodiments" mean that at least one embodiment includes the specific referenced elements, structures, or features described in connection with that embodiment. Thus, the phrases "in one embodiment," "in an embodiment," "in another embodiment," or "in certain embodiments" appearing in different places throughout the specification do not necessarily all refer to the same embodiment. Furthermore, the specific elements, structures, or features may be combined in any appropriate manner in one or more embodiments.

[0018] It should be understood that the singular article "a", "an" and "the" used in the specification of the present disclosure and the appended claims include plural objects unless otherwise clearly specified in the context. Therefore, for example, "adding an acid to the reaction of compound SGL1-A with dimethylaminoacetaldehyde dimethyl acetal and acetic acid hydrazine" includes "adding an acid to the reaction of compound SGL1-A with dimethylaminoacetaldehyde dimethyl acetal and acetic acid hydrazine", or "adding two or more acids to the reaction of compound SGL1-A with dimethylaminoacetaldehyde dimethyl acetal and acetic acid hydrazine".

[0019] definition

[0020] Accordingly, unless otherwise indicated to the contrary, the following terms used in the specification and appended claims shall have the following meanings:

[0021] In the present disclosure, the term "compound SGL1-A" refers to 5-carbamoyl-4-cyclobutyl-2-methylbenzoic acid, which has the following structure:

[0022]

[0023] In the present disclosure, the term "compound SGL1-B" refers to methyl 4-cyclobutyl-2-methyl-5-(5-methyl-4H-1,2,4-triazol-3-yl)benzoate hydrochloride, which has the following structure:

[0024]

[0025] In the present disclosure, the term "compound SGL1-C" refers to 4-cyclobutyl-2-methyl-5-(5-methyl-4H-1,2,4-triazol-3-yl)benzoic acid, which has the following structure:

[0026]

[0027] In the present disclosure, the term "compound SGL1-SM1" refers to 5-cyano-4-cyclobutyl-2-methylbenzoic acid, which has the following structure:

[0028]

[0029] In the present disclosure, the term "compound SGL1-SM2" refers to 4-(piperidin-4-yl)benzonitrile, which has the following structure:

[0030]

[0031] In the present disclosure, the term "compound SGL1" refers to 4-(1-(4-cyclobutyl-2-methyl-5-(5-methyl-4H-1,2,4-triazol-3-yl)benzoyl)piperidin-4-yl)benzonitrile, which has the following structure:

[0032]

[0033] In this disclosure, the term "equivalent" refers to the mass ratio of substances when they interact with each other, and is calculated based on the specific reactants specified.

[0034] In the present disclosure, the term "condensation agent" refers to a reaction auxiliary agent added in the condensation reaction. Specific implementation plan

[0035] In one aspect, the present disclosure relates to a method for preparing compound SGL1-A, comprising: subjecting compound SGL1-SM1 to a hydrolysis reaction under alkaline conditions, wherein an aqueous solution of hydrogen peroxide is added to the hydrolysis reaction.

[0036] In certain embodiments, the concentration of the aqueous solution of hydrogen peroxide that can be used in the present disclosure is about 20 to 70% by mass.

[0037] In certain embodiments, the amount of the aqueous solution of hydrogen peroxide that can be used in the present disclosure to be added is about 7 to 15 equivalents based on compound SGL1-SM1.

[0038] In certain embodiments, the hydrolysis reaction is carried out at about 20 to 30 °C.

[0039] In certain embodiments, the hydrolysis reaction is carried out for about 5 to 10 hours.

[0040] In certain embodiments, illustrative examples of basic conditions that can be used in the method for preparing compound SGL1-A of the present disclosure include, but are not limited to, sodium hydroxide, potassium hydroxide, lithium hydroxide, potassium carbonate, cesium carbonate, sodium carbonate, or any mixture thereof.

[0041] In certain embodiments, hydrogen peroxide can oxidize the easily oxidized cyanide group to a more stable thiocyanate ion (SCN). - ), thereby preventing the cyano group from being hydrolyzed into acid, thereby inhibiting the generation of by-products and improving the yield.

[0042] In certain embodiments, the 10 Kg scale-up yield of the method for preparing compound SGL1-A disclosed herein can reach more than 90%.

[0043] In another aspect, the present disclosure relates to a method for preparing compound SGL1-B, comprising: reacting compound SGL1-A with dimethylaminoacetaldehyde dimethyl acetal and hydrazine acetate.

[0044] In certain embodiments, the amount of dimethylaminoacetaldehyde dimethyl acetal added is about 3.0 to 6.0 equivalents based on compound SGL1-A.

[0045] In certain embodiments, hydrazine acetate is added in an amount of about 1.5 to 3.0 equivalents based on compound SGL1-A.

[0046] In certain embodiments, the reaction is carried out at about 60 to 70 °C.

[0047] In certain embodiments, the product of the reaction of compound SGL1-A with dimethylaminoacetaldehyde dimethyl acetal and hydrazine acetate is purified using an organic solvent.

[0048] In certain embodiments, illustrative examples of organic solvents that can be used to purify the product of the reaction of compound SGL1-A with dimethylaminoacetaldehyde dimethyl acetal and hydrazine acetate include, but are not limited to, methanol, ethanol, isopropanol, methyl tert-butyl ether, n-heptane, isopropyl acetate, acetone, methyl isobutyl ketone, isobutyl acetate, ethyl acetate, or any mixture thereof.

[0049] In certain embodiments, the method for preparing compound SGL1-B further comprises purifying the product of the reaction of compound SGL1-A with dimethylaminoacetaldehyde dimethyl acetal and hydrazine acetate using ethyl acetate.

[0050] In certain embodiments, the method of preparing compound SGL1-B further comprises adding an acid to the reaction of compound SGL1-A with dimethylaminoacetaldehyde dimethyl acetal and hydrazine acetate.

[0051] In certain embodiments, illustrative examples of acids that can be used for the reaction of compound SGL1-A with dimethylaminoacetaldehyde dimethyl acetal and hydrazine acetate include, but are not limited to, formic acid, acetic acid, phosphoric acid, hydrochloric acid, maleic acid, fumaric acid, or any mixture thereof.

[0052] In certain embodiments, the method of preparing compound SGL1-B further comprises adding acetic acid to the reaction of compound SGL1-A with dimethylaminoacetaldehyde dimethyl acetal and hydrazine acetate.

[0053] In certain embodiments, the amount of acid added to the reaction of compound SGL1-A with dimethylaminoacetaldehyde dimethyl acetal and hydrazine acetate is about 4 to 12 equivalents.

[0054] In certain embodiments, in the method for preparing compound SGL1-B, dimethylaminoacetaldehyde dimethyl acetal (DMA-DMA) and hydrazine acetate are reacted in a one-pot process to efficiently configure a 5-membered heterocyclic ring.

[0055] In certain embodiments, the method for preparing compound SGL1-B disclosed herein can achieve a 10 Kg scale-up yield of more than 70%.

[0056] In yet another aspect, the present disclosure relates to a method for preparing compound SGL1-C, comprising: subjecting compound SGL1-B to a hydrolysis reaction under alkaline conditions.

[0057] In certain embodiments, the base is added in an amount of about 3 to 10 equivalents based on compound SGL1-B.

[0058] In certain embodiments, illustrative examples of basic conditions that can be used in the method for preparing compound SGL1-C of the present disclosure include, but are not limited to, sodium hydroxide, potassium hydroxide, lithium hydroxide, potassium carbonate, cesium carbonate, sodium carbonate, or any mixture thereof.

[0059] In certain embodiments, compound SGL1-B is hydrolyzed in the presence of sodium hydroxide.

[0060] In certain embodiments, the hydrolysis reaction is carried out at about 20 to 30 °C.

[0061] In certain embodiments, the hydrolysis reaction is carried out for about 3 to 20 hours.

[0062] In certain embodiments, the method for preparing compound SGL1-C disclosed herein achieves 10 Kg-level scale-up with a yield greater than 70%.

[0063] In yet another aspect, the present disclosure relates to a method for preparing compound SGL1, comprising: reacting compound SGL1-C with compound SGL1-SM2.

[0064] In certain embodiments, the reaction of compound SGL1-C and compound SGL1-SM2 is performed in the presence of a condensing agent.

[0065] In certain embodiments, illustrative examples of condensing agents that can be used for the reaction of compound SGL1-C with compound SGL1-SM2 include, but are not limited to, 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDCI), 2-(7-azabenzotriazole)-N,N,N',N'-tetramethyluronium hexafluorophosphate (HATU), dicyclohexylcarbodiimide (DCC), N,N'-diisopropylcarbodiimide (DIC), 1-hydroxybenzotriazole (HOBT), propyl phosphoric anhydride (T3P), n-butyl phosphoric anhydride (T4P), or any mixture thereof.

[0066] In certain embodiments, the reaction of compound SGL1-C and compound SGL1-SM2 is carried out in the presence of n-butylphosphoric anhydride (T4P).

[0067] In certain embodiments, in the reaction of compound SGL1-C with compound SGL1-SM2, n-butylphosphonic anhydride (T4P) is added in an amount of at least about 1.5 equivalents based on compound SGL1-C.

[0068] In certain embodiments, the reaction of compound SGL1-C and compound SGL1-SM2 is performed under basic conditions.

[0069] In certain embodiments, the base is added in an amount of at least 5 equivalents based on compound SGL1-C.

[0070] In certain embodiments, illustrative examples of basic conditions that can be used in the method for preparing compound SGL1 of the present disclosure include, but are not limited to, N,N-diisopropylethylamine (DIEA), triethylamine (TEA), pyridine (Py), 4-dimethylaminopyridine (DMAP), 2,6-lutidine, N-methylmorpholine (NMM), potassium carbonate, sodium carbonate, or any mixture thereof.

[0071] In certain embodiments, the reaction of compound SGL1-C and compound SGL1-SM2 is performed in the presence of diisopropylethylamine (DIEA).

[0072] In certain embodiments, the amount of compound SGL1-SM2 added is about 1.05 to 5 equivalents based on compound SGL1-C.

[0073] In certain embodiments, the reaction of compound SGL1-C and compound SGL1-SM2 is carried out at 20 to 30 °C.

[0074] In certain embodiments, the reaction of compound SGL1-C and compound SGL1-SM2 is carried out for about 5 to 20 hours.

[0075] In certain embodiments, the method for preparing compound SGL1 disclosed herein performs dehydration condensation in the presence of n-butylphosphoric anhydride (T4P), and efficiently completes the preparation of amide, with a yield of more than 85%.

[0076] In another aspect, the present disclosure relates to a method for preparing compound SGL1, comprising:

[0077] The method for preparing compound SGL1-A described in the present disclosure; and / or

[0078] The method for preparing compound SGL1-B described in the present disclosure; and / or

[0079] The method for preparing compound SGL1-C described in the present disclosure; and / or

[0080] The present disclosure discloses a method for preparing compound SGL1.

[0081] In yet another aspect, the present disclosure relates to a method for preparing compound SGL1, comprising:

[0082] The compound SGL1-SM1 is subjected to a hydrolysis reaction under alkaline conditions to obtain a compound SGL1-A;

[0083] The compound SGL1-A is reacted with dimethylaminoacetaldehyde dimethyl acetal and hydrazine acetate to obtain a compound SGL1-B;

[0084] hydrolyzing the compound SGL1-B under alkaline conditions to obtain a compound SGL1-C; and

[0085] The compound SGL1-C is reacted with the compound SGL1-SM2 to obtain the compound SGL1.

[0086] In certain embodiments, the method for preparing heterocyclic regulators of lipid synthesis disclosed herein can improve yield, reduce impurities, and is suitable for industrial application.

[0087] Hereinafter, the present disclosure will be explained in detail by the following examples in order to better understand the various aspects and advantages of the present application. However, it should be understood that the following examples are non-limiting and are only used to illustrate certain embodiments of the present disclosure.

[0088] Example

[0089] The reagents and equipment used in the examples of the present disclosure are conventional and commercially available. For example:

[0090]

[0091]

[0092] Example 1

[0093] Preparation of compound SGL1-A

[0094]

[0095] Add purified water (6.03 equivalents, 66.33Kg) to the reactor, start stirring and add anhydrous ethanol (2.38 equivalents, 26.18Kg), sodium hydroxide (0.56 equivalents, 6.16Kg), stir evenly and add SGL1-SM1 (1 equivalent, 11Kg), rinse the reactor with purified water (1.05 equivalents, 11.55Kg). Slowly drop 30% hydrogen peroxide aqueous solution (3.73, 41.03Kg), after adding, control the temperature at 25±5℃ and stir for 5 hours, then take a sample and send it to HPLC for IPC-1 detection, and take a sample for detection until the reaction is qualified. Pre-prepare 20% sodium bisulfite (2.9 equivalents, 31.9Kg) water (11.5 equivalents, 126.5Kg) solution, after passing, add 20% sodium bisulfite solution to the reactor, and stir at 25±10℃ for 1 hour. Add hydrochloric acid to adjust the pH to 1 to 2, control the temperature at 25±10°C and stir for 2 hours, filter, and rinse the filter cake with purified water (3.04 equivalents, 33.44 Kg) to obtain a crude wet product of SGL1-A. Add purified water (19.04 equivalents, 209.44Kg) to the reactor, start stirring, add SGL1-A crude wet product, wash the reactor wall with purified water (1.00 equivalents, 11Kg), heat to 35±5℃, keep warm for at least 1 hour, cool to 20±5℃, centrifuge, rinse the filter cake twice with purified water (3.0 equivalents, 33Kg), and obtain SGL1-A refined wet product. Take a sample of the wet product and send it to IPC-2 for analysis; transfer the SGL1-A refined wet product to a vacuum dryer, control the dryer jacket temperature to 55±5℃, dry for 15 hours, take an IPC-3 sample, and test KF and LOD (KF≤0.5%, LOD≤2.0%). After passing the test, cool and collect the powder to obtain SGL1-A dry product, 11.09Kg, with a yield of 93.0%.

[0096] 1 H NMR (500MHz, DMSO-d6) δ12.37(s,1H),7.72(s,1H),7.28(d,J=7.8Hz,1H),7.70(d ,J=7.8Hz,1H),7.22(s,1H),3.11(q,J=5.3Hz,1H),2.45(s,3H),1.97–1.64(m,7H)

[0097] The above Example 1 was repeated using the following process parameters, and the results are shown in Table 1.

[0098] Table 1

[0099] serial number SGL1-SM1 NaOH Hydrogen Peroxide Reaction temperature Yield 1 1.0 equivalent 3.0 equivalent 15.0 equivalent 20 to 30°C 90% 2 1.0 equivalent 3.0 equivalent 7.0 equivalent 20 to 30°C 93% 3 1.0 equivalent 4.0 equivalent - 70 to 80°C 65% 4 1.0 equivalent 2.0 equivalent - 70 to 80°C 40%

[0100] Example 2

[0101] Preparation of compound SGL1-B

[0102]

[0103] Add tetrahydrofuran (6.27 equivalents, 68.97Kg) to the reactor under nitrogen protection and start stirring. Add dimethylaminoacetaldehyde dimethyl acetal (DMA-DMA) (1.7173 equivalents, 18.8903Kg) to the reactor. Add SGL1-A (1.0 equivalents, 11Kg) to the reactor. After the addition is completed, wash the reactor wall with tetrahydrofuran (0.903 equivalents, 9.933Kg), raise the system temperature to 65±5℃, keep warm and stir for 5 hours, take IPC-1 sample for testing, and the central control is qualified. Adjust the temperature in the reactor to 30±10℃. Add hydrazine acetate (0.596 equivalent, 6.556 Kg) into the kettle, and then add acetic acid (1.0724 equivalent, 11.7964 Kg) dropwise. After the addition is complete, continue to stir at 30±10℃ for 30 minutes, then raise the temperature to 50±5℃, stir at this temperature for 2 hours, and then take the IPC-2 sample for testing.

[0104] After the reaction is completed, cool to 30±10℃, add purified water (7.245 equivalents, 79.695Kg) to the reactor, and concentrate to 7 times the volume under reduced pressure under the condition of controlling the temperature ≤50℃. Cool to 20±5℃, stir for 1 hour, then centrifuge and filter. Wash the filter cake with purified water (2.092 equivalents, 23.012Kg) to obtain SGL1-B free state. Transfer the wet product to a vacuum dryer, control the jacket temperature at 45 to 55℃, dry for at least 10 hours, take an IPC-3 sample to test KF, until KF ≤ 2%, and obtain SGL1-B free state dry product. Under nitrogen protection, ethyl acetate (8.265 equivalents, 90.915Kg) was added to the reactor, and stirring was started; SGL1-B free dry product was added, and after the addition was completed, the reactor wall was washed with ethyl acetate (0.878 equivalents, 9.658Kg), stirred for 10 minutes, heated to 60±5°C, kept warm and stirred for 1 hour, then cooled to 25±5°C, the reactor temperature was controlled at 20±10°C, hydrochloric acid (0.51 equivalents, 5.61Kg) was added dropwise, and kept warm and stirred at this temperature for 1 hour, centrifuged, and the filter cake was washed with ethyl acetate (3.571 equivalents, 39.28Kg) to obtain SGL1-B wet product; the SGL1-B wet product was transferred to a vacuum dryer, the jacket temperature was controlled at 45 to 55°C, and dried for at least 10 hours, and an IPC-5 sample was taken to detect LOD, until LOD ≤ 2%. After passing the test, the dry product SGL1-B was obtained, 10.87 kg, with a yield of 71.6%.

[0105] 1H NMR (500MHz, DMSO-d6) δ11.05(s,2H),8.49(s,2H),7.34(s,2H),3.88(s,6H),3.29(dd,J=5.6,4.9Hz,2H),2.78(s, 6H),2.50(s,6H),1.96–1.87(m,4H),1.87–1.81(m,1H),1.81–1.76(m,5H),1.75(d,J=1.7Hz,1H),1.74–1.64(m,2H)

[0106] The above Example 2 was repeated using the following process parameters, and the results are shown in Table 2.

[0107] Table 2

[0108] serial number SGL1-A DMA-DMA Hydrazine acetate Acetic acid Reaction temperature Yield 1 1.0 equivalent 3.0 equivalent 1.5 equivalent 4.0 equivalent 60 to 70°C 71.6% 2 1.0 equivalent 1.0 equivalent 1.5 equivalent 4.0 equivalent 60 to 70°C 10% 3 1.0 equivalent 2.0 equivalent 1.5 equivalent 4.0 equivalent 60 to 70°C 55% 4 1.0 equivalent 6.0 equivalent 1.5 equivalent 4.0 equivalent 60 to 70°C 72% 5 1.0 equivalent 3.0 equivalent 1.5 equivalent 7.0 equivalent 60 to 70°C 71% 6 1.0 equivalent 3.0 equivalent 1.0 equivalent 4.0 equivalent 60 to 70°C 40% 7 1.0 equivalent 3.0 equivalent 3.0 equivalent 4.0 equivalent 60 to 70°C 70% 8 1.0 equivalent 3.0 equivalent 1.5 equivalent 4.0 equivalent 40 to 50°C 30%

[0109] Example 3

[0110] Preparation of compound SGL1-C

[0111]

[0112] Under nitrogen protection, methanol (3.58 equivalents, 38.66Kg) was added to the reactor, stirring was started, purified water (1.53 equivalents, 16.52Kg) was added to the reactor, the temperature in the reactor was controlled below 50°C, sodium hydroxide (0.369 equivalents, 3.99Kg) was added to the reactor, stirring for at least 30 minutes, and then SGL1-B (1.0 equivalents, 10.80Kg) was added. After the addition was completed, the reactor wall was washed with methanol (0.82 equivalents, 8.86Kg), and then the system temperature was raised to 60±5°C, and the mixture was stirred for 3 hours and IPC-1 samples were taken for testing, and SGL1-B was required to be ≤0.5%. After passing the test, the temperature in the reactor was lowered to 40±5°C, purified water (4.77 equivalents, 51.52Kg) was added to the reactor, and the mixture was concentrated to 6 times the volume under reduced pressure. The temperature in the kettle was lowered to 20±10℃, hydrochloric acid was added dropwise at this temperature to adjust the pH to 1 to 3, and the mixture was stirred for 1 hour under heat preservation, and centrifuged. The filter cake was rinsed with purified water (5.0 equivalents, 54Kg) to obtain SGL1-C wet product. The qualified wet product was transferred to a vacuum dryer, the jacket temperature was controlled at 40 to 55℃, and dried for at least 10 hours. The IPC-3 sample was taken to test KF until KF ≤ 0.5%, and SGL1-C dry product was obtained, 8.79Kg, with a yield of 96.6%.

[0113] 1H NMR(500MHz,DMSO-d6)δ12.06(s,1H),10.98(s,1H),8.21(s,1H),7.27(s,1H),3.34(dd,J=5.6,4.9Hz,1H),2.43(d,J =16.1Hz,6H),1.98–1.87(m,3H),1.84(dd,J=7.6,5.3Hz,1H),1.84–1.78(m,2H),1.81–1.71(m,1H),1.74–1.66(m,1H)

[0114] The above Example 3 was repeated using the following process parameters. The results are shown in Table 3.

[0115] Table 3

[0116] serial number SGL1-B NaOH Reaction temperature Reaction time Yield 1 1.0 equivalent 3.0 equivalent 20 to 30°C 3h 98% 2 1.0 equivalent 2.0 equivalent 20 to 30°C 3h 93%

[0117] Example 4

[0118] Preparation of compound SGL1

[0119]

[0120] Add dichloromethane (6.88 equivalents, 60.54Kg) to the reactor under nitrogen protection and start stirring. Add SGL1-C (1.0 equivalents, 8.8Kg) and SGL1-SM2 (0.86 equivalents, 7.6Kg) to the reactor; after the addition is completed, wash the reactor wall with dichloromethane (1.34 equivalents, 11.79Kg); adjust the temperature of the reactor to 15±5℃, add N,N-diisopropylethylamine (2.36 equivalents, 20.77Kg) dropwise, add butyl phosphoric anhydride 50% ethyl acetate solution (4 equivalents, 35.2Kg) dropwise, adjust the room temperature after the addition is completed, react for 2 hours, and send to IPC-1 for testing, requiring SGL1-C ≤2%. After passing the test, ethyl acetate (9.03 equivalents, 79.46Kg) was added to the kettle, and the mixture was concentrated to 15 times the volume under reduced pressure at 40°C. Purified water (5.06 equivalents, 44.53Kg) was added, stirred for 2 hours, centrifuged, and the filter cake was washed with purified water (1.99 equivalents, 17.51Kg) to obtain SGL1 wet product 1. Anhydrous ethanol (2.73 equivalents, 24.02Kg) was added to the kettle, stirring was started, and SGL1 wet product 1 was added. The temperature in the kettle rose to 78±5°C, and the mixture passed through a precision filter into the clean area at this temperature. Purified water (1.74 equivalents, 15.31Kg) was added dropwise after filtration, and the mixture was stirred at this temperature for at least 0.5 hours. The system temperature was reduced to 15±10°C within 6 hours, and the mixture was stirred at this temperature for 6 hours. After centrifugation, the filter cake was washed with a 1:1 ethanol (0.47 equivalent, 4.14 Kg) and purified water (0.47 equivalent, 4.14 Kg) mixed solution to obtain SGL1 refined wet product, and IPC-2 sample was taken for detection; the SGL1 refined wet product was dried under reduced pressure at 40 to 55°C for 10 hours, and IPC-3 sample was taken for GC detection of the residual solvent until it met the standard. SGL1 was obtained, 13.085 Kg, with a yield of 88.1%.

[0121] 1 HNMR(400MHz,DMSO-d6)δ13.66(s,1H),7.75(d,J=8.0Hz,2H),7.55(s,1H),7.47 (d,J=8.0Hz,2H),7.37(s,1H),4.72(d,J=12.5Hz,1H),4.31(s,1H),3.44(m,1H) ,3.13(t,J=12.0Hz,1H),2.90-2.85(m,2H),2.39(s,3H),2.36-2.26(m,3H),2.1 7(s,2H),2.07-2.00(m,2H),1.89-1.71(m,3H),1.67-1.64(m,2H),1.46(s,1H).

[0122] The above Example 4 was repeated using the following process parameters, and the results are shown in Table 4.

[0123] Table 4

[0124]

[0125] In the present disclosure, relational terms such as first and second, etc. are used merely to distinguish one entity or operation from another entity or operation, but do not necessarily require or imply any such actual relationship or order between these entities or operations.

[0126] It can be understood from the foregoing that although the specific embodiments of the present disclosure are described for the purpose of illustrative illustration, various modifications or improvements may be made by those skilled in the art without departing from the spirit and scope of the present disclosure. These modifications or improvements should all fall within the scope of the claims appended to the present disclosure.

Claims

1. A method for preparing compound SGL1-A, comprising: The compound SGL1-SM1 is subjected to a hydrolysis reaction under alkaline conditions, wherein an aqueous solution of hydrogen peroxide is added to the hydrolysis reaction.

2. The method of claim 1, wherein: The amount of the aqueous solution of hydrogen peroxide added is 7 to 15 equivalents based on the compound SGL1-SM1.

3. The method of claim 1 or 2, wherein the hydrolysis reaction is carried out at 20 to 30°C.

4. A method for preparing compound SGL1-B, comprising: The compound SGL1-A is reacted with dimethylaminoacetaldehyde dimethyl acetal and hydrazine acetate.

5. The method of claim 4, wherein the amount of dimethylaminoacetaldehyde dimethyl acetal added is 3.0 to 6.0 equivalents based on the compound SGL1-A.

6. The method according to claim 4 or 5, wherein the amount of hydrazine acetate added is 1.5 to 3.0 equivalents based on the compound SGL1-A.

7. The process according to any one of claims 4 to 6, wherein the reaction is carried out at 60 to 70°C.

8. The method according to any one of claims 4 to 7, further comprising refining the product of the reaction of compound SGL1-A with dimethylaminoacetaldehyde dimethyl acetal and hydrazine acetate using an organic solvent, preferably methanol, ethanol, isopropanol, methyl tert-butyl ether, n-heptane, isopropyl acetate, acetone, methyl isobutyl ketone, isobutyl acetate, ethyl acetate or any mixture thereof, more preferably ethyl acetate.

9. The method according to any one of claims 4 to 8, further comprising adding an acid, preferably formic acid, acetic acid, phosphoric acid, hydrochloric acid, maleic acid, fumaric acid or any mixture thereof, more preferably acetic acid, to the reaction of compound SGL1-A with dimethylaminoacetaldehyde dimethyl acetal and hydrazine acetate.

10. A method for preparing compound SGL1-C, comprising: The compound SGL1-B is subjected to a hydrolysis reaction under alkaline conditions.

11. The method of claim 10, wherein the base is added in an amount of 3 to 10 equivalents based on the compound SGL1-B.

12. The method of claim 10 or 11, wherein the alkaline condition is selected from sodium hydroxide, potassium hydroxide, lithium hydroxide, potassium carbonate, cesium carbonate, sodium carbonate or any mixture thereof, preferably sodium hydroxide.

13. The process according to any one of claims 10 to 12, wherein the hydrolysis reaction is carried out at 20 to 30°C.

14. The method according to any one of claims 10 to 13, wherein the hydrolysis reaction is carried out for 3 to 20 hours.

15. A method for preparing compound SGL1, comprising: The compound SGL1-C is reacted with the compound SGL1-SM2.

16. The method of claim 15, wherein the reaction is carried out in the presence of a condensing agent, preferably the condensing agent is selected from 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDCI), 2-(7-azabenzotriazole)-N,N,N',N'-tetramethyluronium hexafluorophosphate (HATU), dicyclohexylcarbodiimide (DCC), N,N'-diisopropylcarbodiimide (DIC), 1-hydroxybenzotriazole (HOBT), propyl phosphoric anhydride (T3P), n-butyl phosphoric anhydride (T4P) or any mixture thereof, more preferably n-butyl phosphoric anhydride (T4P), and even more preferably, the amount of n-butyl phosphoric anhydride (T4P) added is at least 1.5 equivalents based on the compound SGL1-C.

17. The method of claim 15 or 16, wherein the reaction is carried out under basic conditions, preferably the base is added in an amount of at least 5 equivalents based on the compound SGL1-C.

18. The method of claim 17, wherein the alkaline condition is selected from N,N-diisopropylethylamine (DIEA), triethylamine (TEA), pyridine (Py), 4-dimethylaminopyridine (DMAP), 2,6-lutidine, N-methylmorpholine (NMM), potassium carbonate, sodium carbonate or any mixture thereof, preferably diisopropylethylamine (DIEA).

19. A method for preparing compound SGL1, comprising: The method according to any one of claims 1 to 3; and / or The method of any one of claims 4 to 9; and / or The method of any one of claims 10 to 14; and / or A method as claimed in any one of claims 15 to 18.

20. A method for preparing compound SGL1, comprising: The compound SGL1-SM1 is subjected to a hydrolysis reaction under alkaline conditions to obtain a compound SGL1-A; The compound SGL1-A is reacted with dimethylaminoacetaldehyde dimethyl acetal and hydrazine acetate to obtain a compound SGL1-B; The compound SGL1-B is subjected to a hydrolysis reaction under alkaline conditions to obtain a compound SGL1-C; as well as The compound SGL1-C is reacted with the compound SGL1-SM2 to obtain the compound SGL1.

Citation Information

Cited By

  • Industrial preparation of heterocyclic modulator for lipid synthesis

    EP4722204A1

  • Industrial preparation of heterocyclic modulator for lipid synthesis

    WO2024251076A1